Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.

Saved in:
Bibliographic Details
Title: Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.
Authors: Klocker EV; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria., Hasenleithner S; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Austria., Bartsch R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria., Gampenrieder SP; Third Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Austria., Egle D; Department of Gynecology, Breast Cancer Center Tirol, Medical University of Innsbruck, Austria., Singer CF; Department of Gynecology, Breast Cancer Center Vienna, Medical University of Vienna, Austria., Rinnerthaler G; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria., Hubalek M; Department of Gynecology, Breast Health Center Schwaz, Austria., Schmitz K; Institute of Pathology, University Medical Center Göttingen, Germany.; Tyrolpath Obrist Brunhuber GmbH and Krankenhaus St. Vinzenz, Zams, Austria., Bago-Horvath Z; Department of Pathology, Medical University Vienna, Austria., Petzer A; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Barmherzige Schwestern, Elisabethinen, Ordensklinikum Linz GmbH, Austria., Heibl S; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen GmbH, Austria., Heitzer E; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Christian Doppler Laboratory for Liquid Biopsies for early Detection of Cancer, Medical University of Graz, Austria., Balic M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria.; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, PA, USA., Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Austria.
Source: Molecular oncology [Mol Oncol] 2025 Jul; Vol. 19 (7), pp. 1897-1917. Date of Electronic Publication: 2024 Jun 12.
Publication Type: Journal Article; Review
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.13671